Type 2 Diabetes Mellitus Therapeutics Market 2022 Type 2 Diabetes Mellitus Therapeutics Market 2022 Clique para ler
  • Comentários

Type 2 Diabetes Mellitus Therapeutics Market 2022

Type 2 Diabetes Mellitus Therapeutics Market 2022

Publicado no e em "Negócios", idioma — English. 6 páginas.
The current South-East Asia T2DM market contains novel products, including Jardiance, a SGLT-2 inhibitor; Victoza, a GLP-1 receptor agonist; and Januvia, a DPP-4 inhibitor. Mais
Assine GRÁTIS